304
Views
43
CrossRef citations to date
0
Altmetric
Original Research

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens

, &
Pages 1225-1231 | Published online: 25 Aug 2015

References

  • SorliCHeileMKIdentifying and meeting the challenges of insulin therapy in type 2 diabetesJ Multidiscip Healthc2014726728225061317
  • PeyrotMRubinRRPerceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients’ cognitive frameworkPatient Prefer Adherence2011525526521792298
  • PhillipsLSBranchWTCookCBClinical inertiaAnn Intern Med2001135982583411694107
  • BuysmanEConnerCAagrenMBouchardJLiuFAdherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetesCurr Med Res Opin20112791709171721740289
  • CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
  • CheenHHLimSHHuangMCBeeYMWeeHLAdherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in SingaporeClin Ther20143671043105324913030
  • Del PratoSPennoGMiccoliRChanging the treatment paradigm for type 2 diabetesDiabetes Care200932Suppl 2S217S22219875555
  • PeyrotMBarnettAHMeneghiniLFSchumm-DraegerPMInsulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabet Med201229568268922313123
  • MorrisADBoyleDIMcMahonADGreeneSAMacDonaldTMNewtonRWDARTS/MEMO CollaborationAdherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitusLancet19973509090150515109388398
  • AronsonRThe role of comfort and discomfort in insulin therapyDiabetes Technol Ther201214874174722537418
  • WrightABurdenACPaiseyRBCullCAHolman RR;UK. Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)Diabetes Care200225233033611815505
  • pharmafile.com [homepage on the Internet]Treatment flexibility will improve adherence in diabetes, study suggestsSamedan Ltd2011 Available from: http://www.pharmafile.com/news/161079/treatment-flexibility-will-improve-adherence-diabetes-study-suggestsAccessed July 2, 2015
  • PetersonAMNauDPCramerJABennerJGwadry-SridharFNicholMA checklist for medication compliance and persistence studies using retrospective databasesValue Health200710131217261111
  • PeyrotMBarnettAHMeneghiniLFSchumm-DraegerPMFactors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabetes Obes Metab2012141081108722726104
  • SpannSJNuttingPAGalliherJMManagement of type 2 diabetes in the primary care setting: a practice-based research network studyAnn Fam Med200641233116449393
  • KarterAJSubramanianUSahaCBarriers to insulin initiation: the translating research into action for diabetes insulin starts projectDiabetes Care201033473373520086256
  • PeyrotMRubinRRKrugerDFTravisLBCorrelates of insulin injection omissionDiabetes Care201033224024520103556
  • DaileyGKimMSLianJFPatient compliance and persistence with anti-hyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitusClin Ther20012381311132011558867
  • BonafedeMMKalsekarAPawaskarMA retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixturesPatient Prefer Adherence2010414715620622915
  • KnechtLAGauthierSMCastroJCDiabetes care in the hospital: is there clinical inertia?J Hosp Med20061315116017219489
  • SchnipperJLBarskyEEShaykevichSFitzmauriceGPendergrassMLInpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospitalJ Hosp Med20061314515017219488
  • RatnerRWynneANakhleSBruscoOVlajnicARendellMInfluence of preprandial vs postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096)Diabetes Obes Metab201113121142114821812890
  • VinagreISánchez-HernándezJSánchez-QuesadaJLMaríaMÁde LeivaAPérezASwitching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimensEndocrinol Nutr201360524925323523346
  • FritscheALarbigMOwensDHäringHUGINGER study groupComparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER studyDiabetes Obes Metab201012211512320092584
  • LieblAPragerRBinzKKaiserMBergenstalRGallwitzBPREFER Study GroupComparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trialDiabetes Obes Metab2009111455218643839
  • RosenstockJAhmannAJColonGScism-BaconJJiangHMartinSAdvancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapyDiabetes Care2008311202517934150
  • OliveriaSAMendittoLAUlcickas YoodMKooYHWellsKEMcCarthyBDBarriers to the initiation of, and persistence with, insulin therapyCurr Med Res Opin200723123105311217977482
  • OdegardPSCapocciaKMedication taking and diabetes: a systematic review of the literatureDiabetes Educ200733610141029 discussion 1030–103118057270
  • KorytkowskiMBellDJacobsenCSuwannasariRFlexPen Study TeamA multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClin Ther200325112836284814693308
  • FloodTAdvances in insulin delivery systems and devices: beyond the vial and syringeInsulin20061399108
  • NakarSYitzhakiGRosenbergRVinkerSTransition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriersJ Diabetes Complications200721422022617616351
  • PolonskyWHHajosTRDainMPSnoekFJAre patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international populationCurr Med Res Opin20112761169117421469914
  • HayesRPFitzgeraldJTJacoberSJPrimary care physician beliefs about insulin initiation in patients with type 2 diabetesInt J Clin Pract200862686086818393965
  • BenroubiMFear, guilt feelings and misconceptions: barriers to effective insulin treatment in type 2 diabetesDiabetes Res Clin Pract201193Suppl 1S97S9921864760
  • PetznickAMIdentifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitusJ Am Osteopath Assoc20131134 Suppl 2S6S1623545891
  • TurnerRCCullCAFrighiVHolmanRRGlycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) GroupJAMA1999281212005201210359389
  • American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437Suppl 1S14S8024357209
  • RodbardHWJellingerPSDavidsonJAStatement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlEndocr Pract200915654055919858063
  • LaSalleJREmpowering patients during insulin initiation: a real-world approachJ Am Osteopath Assoc20101102697820160245